| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2023 |
3
| Cohen Darrel P. (Chief Medical Officer) has filed a Form 3 on Viracta Therapeutics, Inc. |
| 06/09/2023 |
4
| Simon Barry J. (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| Rubino Stephen (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| Murphy Samuel Lafayette (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| DARCY THOMAS E (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| Chung Jane (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| Borellini Flavia (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/09/2023 |
4
| Barlow Jane F (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 05/26/2023 |
4
| ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 25,219 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 9,035 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 3,635 shares
@ $1.4196, valued at
$5.2k
Exercised 6,889 restricted stock units
@ $0 |
|
| 03/17/2023 |
4
| Rothera Mark (President and CEO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.65, valued at
$660k
|
|
| 03/17/2023 |
4
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.65, valued at
$247.5k
|
|
| 03/17/2023 |
4
| Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.65, valued at
$330k
|
|
| 02/28/2023 |
4
| ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 25,219 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 2,156 shares
@ $1.6812, valued at
$3.6k
Exercised 4,127 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 9,034 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 3,599 shares
@ $1.6812, valued at
$6.1k
Exercised 6,889 restricted stock units
@ $0 |
|
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2022 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 9,034 restricted stock units
@ $0 |
|
| 11/29/2022 |
4
| ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 25,219 restricted stock units
@ $0 |
|
| 09/19/2022 |
4
| Rothera Mark (President and CEO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 1,375,000 options to buy
@ $5.21, valued at
$7.2M
|
|
| 09/19/2022 |
3
| Rothera Mark (President and CEO) has filed a Form 3 on Viracta Therapeutics, Inc. |
| 08/29/2022 |
4
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 2,190 shares
@ $4.0118, valued at
$8.8k
Exercised 4,127 restricted stock units
@ $0 |
|
| 08/29/2022 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 9,034 restricted stock units
@ $0 |
|
| 08/29/2022 |
4
| Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 3,655 shares
@ $4.0162, valued at
$14.7k
Exercised 6,889 restricted stock units
@ $0 |
|
| 08/29/2022 |
4
| ROYSTON IVOR (CEO & President) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 13,379 shares
@ $4.0105, valued at
$53.7k
Exercised 25,219 restricted stock units
@ $0 |
|
| 08/11/2022 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 30,282 options to buy
@ $3.69, valued at
$111.7k
|
|
| 08/11/2022 |
4
| Chung Jane (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $3.69, valued at
$295.2k
|
|
|